Abbott launches Freenome’s colorectal cancer screening test

Abbott will sell Freenome’s SimpleScreen CRC test in the U.S. alongside the Cologuard Plus stool-based test it gained in the $21 billion acquisition of Exact Sciences.

Abbott Laboratories (ABT) Launches Ensure Max Protein As Undervalued View Faces A Fresh Test

Abbott Laboratories (ABT) just introduced Ensure Max Protein 3-in-1 Muscle Support, a powder that combines protein, creatine ...
FierceBiotech

Abbott advances its hand-held, rapid blood test for TBI, concussions with new FDA clearance

Abbott said its 15-minute, hand-held blood test could help rule out the need for imaging scans to check for tissue damage in the 24 hours following a possible concussion or traumatic brain injury.
Morningstar%2c Inc.

Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio

Only Abbott offers a complete screening solution combining end-to-end support with both stool- and blood-based colorectal cancer screening options, giving healthcare providers more ways to help ...
FierceBiotech

Abbott's lab-based blood test for concussion scores FDA nod

Abbott's lab-based concussion test looks for two biomarkers in the blood, both of which have been closely linked to traumatic brain injuries when found in elevated concentrations. In studies, it was ...
Nasdaq

Abbott's BinaxNOW™ Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test Use

ABBOTT PARK, Ill., March 31, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non ...